← Leaderboards
Dan L. Longo
Aging
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Human Tissue”
- David Heimbrook · Leidos Biomedical Research, Inc.$294,443,261
- Lawrence Corey · Fred Hutchinson Cancer Center$212,638,156
- Larry Arthur$131,303,476
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$114,079,276
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
Research focus
Human TissueLeukocyte Activation /TransformationCell LineNeoplasm /Cancer GeneticsAgingNeoplasm /Cancer ImmunologyGraft Versus Host DiseaseImmune ResponseGene Induction /RepressionLaboratory MouseMutantCell Growth RegulationBiological Signal TransductionP53 Gene /ProteinAntigensPhosphorylcholineImmunosuppressionMediatingCellsCytokineCd28 MoleculeCyclosporinesInterferon GammaPlay
Grant awards (37)
Rapamycin-sensitive pathway of T cell Activation$481,121
Z01 · FY2008 · AG · contact PI
Structure-function relationship of NFkB p65$347,780
Z01 · FY2008 · AG · contact PI
Characterization Of TGF-b Signaling In a B-cell Lymphoma Cell Line$329,476
Z01 · FY2008 · AG · contact PI
Shaping The Preimmune B Cell Repertoire$201,346
Z01 · FY2008 · AG · contact PI
Rapamycin-sensitive pathway of T cell Activation$280,716
Z01 · FY2007 · AG · contact PI
Shaping The Preimmune B Cell Repertoire$260,665
Z01 · FY2007 · AG · contact PI
Tumor-induced Immunosuppression$240,614
Z01 · FY2007 · AG · contact PI
Tumor-induced Immunosuppression$0
Z01 · FY2006 · AG · contact PI
Shaping The Preimmune B Cell Repertoire$0
Z01 · FY2006 · AG · contact PI
Rapamycin-sensitive pathway of T cell Activation$0
Z01 · FY2006 · AG · contact PI
Rapamycin-sensitive pathway of T cell Activation$0
Z01 · FY2005 · AG
Tumor-induced Immunosuppression$0
Z01 · FY2005 · AG
Shaping The Preimmune B Cell Repertoire$0
Z01 · FY2005 · AG
Cyclosporin A-resistant Co-stimulation Via CD28$0
Z01 · FY2004 · AG
Tumor-induced Immunosuppression$0
Z01 · FY2004 · AG
Shaping The Preimmune B Cell Repertoire$0
Z01 · FY2004 · AG
Role Of Pten In T Cell Activation$0
Z01 · FY2004 · AG
Regulation Of Mutant P53$0
Z01 · FY2004 · AG
Shaping The Preimmune B Cell Repertoire$0
Z01 · FY2003 · AG
Tumor-induced Immunosuppression$0
Z01 · FY2003 · AG
Cyclosporin A-resistant Co-stimulation Via CD28$0
Z01 · FY2003 · AG
Regulation Of Mutant P53$0
Z01 · FY2003 · AG
Tumor-induced Immunosuppression$0
Z01 · FY2002 · AG
Shaping The Preimmune B Cell Repertoire$0
Z01 · FY2002 · AG
Regulation Of Interferon-gamma Gene In Freshly Different$0
Z01 · FY2002 · AG
Regulation Of Mutant P53$0
Z01 · FY2002 · AG
Cyclosporin A-resistant Co-stimulation Via CD28$0
Z01 · FY2002 · AG
Tumor Induced Immunosuppression$0
Z01 · FY2001 · AG
Regulation Of Interferon-gamma Gene In Th1 And Th2 Cells$0
Z01 · FY2001 · AG
Regulation Of Mutant P53$0
Z01 · FY2001 · AG
Cyclosporin A Resistant Costimulation Via Cd28$0
Z01 · FY2001 · AG
Role Of Cadherins In Tumor Progression$0
Z01 · FY2001 · AG
TUMOR INDUCED IMMUNOSUPPRESSION$0
Z01 · FY2000 · AG
ROLE OF SAP IN LYMPHOCYTE SUB POPULATIONS$0
Z01 · FY2000 · AG
REGULATION OF MUTANT P53$0
Z01 · FY2000 · AG
CYCLOSPORIN A RESISTANT CO STIMULATION VIA CD28$0
Z01 · FY2000 · AG
ROLE OF CADHERINS IN TUMOR PROGRESSION$0
Z01 · FY2000 · AG